• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bacteria eats greenhouse gas with a side of protein

Bioengineer by Bioengineer
March 22, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Amy Rosenzweig Lab, Northwestern University

EVANSTON, Ill. — With the ability to leech heavy metals from the environment and digest a potent greenhouse gas, methanotrophic bacteria pull double duty when it comes to cleaning up the environment.

But before researchers can explore potential conservation applications, they first must better understand the bacteria's basic physiological processes. Northwestern University's Amy C. Rosenzweig recently has constructed another section of the puzzle. Her laboratory has identified two never-before-studied proteins, called MbnB and MbnC, as partially responsible for the bacteria's inner workings.

"Our findings extend far beyond methanotrophic bacteria," said Rosenzweig, the Weinberg Family Distinguished Professor of Life Sciences and professor of molecular biosciences and chemistry in Northwestern's Weinberg College of Arts and Sciences. "These two proteins are found in a range of other bacteria, including human pathogens."

The paper publishes tomorrow, March 23, in the journal Science.

Methanotrophic bacteria, or more simply "methanotrophs," take copper from the environment to install into the molecular machinery that metabolizes methane, turning it into methanol for food. To acquire copper, many methanotrophs secrete a chemically modified peptide called methanobactin, which tightly binds to copper ions to pull them into the cell. Until now, the cellular machinery that drives the formation of methanobactin has been little understood.

Rosenzweig's team discovered that two proteins – MbnB and MbnC – are partially responsible for the production of methanobactin. Together, these proteins form an iron-containing enzyme complex that converts an amino acid into two organic chemical groups. This chemistry results in methanobactin, which recruits copper into the cell. Rosenzweig and her team also discovered that these two proteins drive methanobactin production across all families of methanobactin-producing species, including non-methanotrophs.

"The involvement of a metal-requiring enzyme in forming these types of chemical groups is unprecedented, and neither of the two proteins have been studied previously," Rosenzweig said. "Moreover, similar enzymes seem to be produced in other contexts, suggesting that this chemistry is important beyond the production of methanobactin."

This discovery makes it easier for researchers to study methanobactin because they can work with the proteins in test tubes rather than manipulate entire living microorganisms. It also brings the world closer to methanotrophs' promising applications. Many people imagine using filters constructed from the bacteria to scrub methane out of the atmosphere or to help remove methane from natural gas reserves. But Rosenzweig believes that because of methanobactin production, methanotrophs have applications that extend beyond cleaning up the environment.

Because methanobactin binds copper so tightly, it has been investigated as a treatment for Wilson disease, a rare genetic disorder in which patients' bodies cannot eliminate the copper they ingest in food, so it accumulates in the brain and liver. Some researchers also believe that methanobactin has antibacterial properties and could be used in a new class of antibiotics.

"Now that we know which microbial genes and proteins to look for, and now that we know what some of the key proteins do, we can effectively predict which species will make new and different methanobactins," Rosenzweig said. "And we can test those compounds for bioactivities."

###

The study is titled "The biosynthesis of methanobactin." Grace E. Kenney, a graduate student in Rosenzweig's laboratory, served as the paper's first author.

The research was supported by the National Institutes of Health (award numbers GM118035, R01AT009143, U54-GM094662, U54 GM093342, P01 GM118303, R00GM111978 and F32GM110934 and by the National Science Foundation (award numbers MCB0842366 and MCB1330784).

Media Contact

Amanda Morris
[email protected]
847-467-6790
@northwesternu

http://www.northwestern.edu

Related Journal Article

http://dx.doi.org/10.1126/science.aap9437

Share12Tweet8Share2ShareShareShare2

Related Posts

Tracking the Language of Molecules

Tracking the Language of Molecules

August 22, 2025
Blocking Programmed Cell Death: A New Approach to Treating Rare Childhood Diseases

Blocking Programmed Cell Death: A New Approach to Treating Rare Childhood Diseases

August 22, 2025

G9a-Driven H3K9me2 Modification Safeguards Centromere Integrity

August 22, 2025

Redefining Healthy Longevity: How Science, Technology, and Investment Are Shaping the Future

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Brain Area 46: The Hub of Emotion Regulation in Marmosets

New Insights into the Cumulative HBsAg/HBV DNA Ratio in Immune-Tolerant Hepatitis B Patients

Anti-PD-1 Boosts Gastric Cancer with Hepatitis B

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.